Perspective Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Perspective Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2010 to Q3 2024.
  • Perspective Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$15.1M, a 46% decline year-over-year.
  • Perspective Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$63.8M, a 154% decline year-over-year.
  • Perspective Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$46.5M, a 332% decline from 2022.
  • Perspective Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$10.8M, a 218% decline from 2021.
  • Perspective Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$3.39M, a 1.71% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$63.8M -$15.1M -$4.77M -46% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$59M -$11.7M -$598K -5.38% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$58.4M -$12.3M -$11.9M -3211% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$46.5M -$24.7M -$21.4M -655% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$25.1M -$10.4M -$6.29M -155% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$18.8M -$11.1M -$9.03M -434% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$9.78M -$371K +$976K +72.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$10.8M -$3.27M -$1.66M -104% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$9.1M -$4.07M -$1.83M -81.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$7.27M -$2.08M -$1.02M -95.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$6.26M -$1.35M -$602K -80.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$5.65M -$1.6M -$736K -84.8% Oct 1, 2021 Dec 31, 2021 10-K 2022-09-28
Q3 2021 -$4.92M -$2.24M -$1.53M -215% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$3.39M -$1.06M +$127K +10.7% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-28
Q1 2021 -$3.51M -$745K -$200K -36.7% Jan 1, 2021 Mar 31, 2021 10-K 2022-09-28
Q4 2020 -$3.31M -$868K +$29K +3.23% Oct 1, 2020 Dec 31, 2020 10-K 2022-09-28
Q3 2020 -$3.34M -$713K +$103K +12.6% Jul 1, 2020 Sep 30, 2020 10-K 2022-09-28
Q2 2020 -$3.45M -$1.19M -$93K -8.49% Apr 1, 2020 Jun 30, 2020 10-K 2021-09-27
Q1 2020 -$3.35M -$545K +$582K +51.6% Jan 1, 2020 Mar 31, 2020 10-K 2021-09-27
Q4 2019 -$3.94M -$897K +$517K +36.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-09-27
Q3 2019 -$4.45M -$816K +$692K +45.9% Jul 1, 2019 Sep 30, 2019 10-K 2021-09-27
Q2 2019 -$5.14M -$1.1M +$1.25M +53.3% Apr 1, 2019 Jun 30, 2019 10-K 2020-09-25
Q1 2019 -$6.39M -$1.13M +$205K +15.4% Jan 1, 2019 Mar 31, 2019 10-K 2020-09-25
Q4 2018 -$6.6M -$1.41M +$49K +3.35% Oct 1, 2018 Dec 31, 2018 10-K 2020-09-25
Q3 2018 -$6.65M -$1.51M +$38K +2.46% Jul 1, 2018 Sep 30, 2018 10-K 2020-09-25
Q2 2018 -$6.68M -$2.34M -$489K -26.4% Apr 1, 2018 Jun 30, 2018 10-K 2019-09-27
Q1 2018 -$6.2M -$1.33M +$28K +2.06% Jan 1, 2018 Mar 31, 2018 10-K 2019-09-27
Q4 2017 -$6.22M -$1.46M -$13K -0.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-09-27
Q3 2017 -$6.21M -$1.55M -$48K -3.2% Jul 1, 2017 Sep 30, 2017 10-K 2019-09-27
Q2 2017 -$6.16M -$1.85M -$669K -56.5% Apr 1, 2017 Jun 30, 2017 10-K 2018-09-26
Q1 2017 -$5.49M -$1.36M -$165K -13.8% Jan 1, 2017 Mar 31, 2017 10-K 2018-09-26
Q4 2016 -$5.33M -$1.45M -$138K -10.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-09-26
Q3 2016 -$5.19M -$1.5M -$479K -47% Jul 1, 2016 Sep 30, 2016 10-K 2018-09-26
Q2 2016 -$4.71M -$1.19M -$150K -14.5% Apr 1, 2016 Jun 30, 2016 10-K 2017-09-28
Q1 2016 -$4.56M -$1.2M -$241K -25.3% Jan 1, 2016 Mar 31, 2016 10-K 2017-09-28
Q4 2015 -$4.32M -$1.31M -$405K -44.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-09-28
Q3 2015 -$3.91M -$1.02M -$233K -29.7% Jul 1, 2015 Sep 30, 2015 10-K 2017-09-28
Q2 2015 -$3.68M -$1.03M +$643K +38.3% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-09
Q1 2015 -$4.32M -$954K +$1.13M +54.2% Jan 1, 2015 Mar 31, 2015 10-K 2016-09-09
Q4 2014 -$5.45M -$907K +$20K +2.16% Oct 1, 2014 Dec 31, 2014 10-K 2016-09-09
Q3 2014 -$5.47M -$786K +$485K +38.2% Jul 1, 2014 Sep 30, 2014 10-K 2016-09-09
Q2 2014 -$5.96M -$1.68M -$684K -68.9% Apr 1, 2014 Jun 30, 2014 10-K 2015-09-14
Q1 2014 -$5.27M -$2.08M -$1.37M -191% Jan 1, 2014 Mar 31, 2014 10-K 2015-09-14
Q4 2013 -$3.91M -$927K +$227K +19.7% Oct 1, 2013 Dec 31, 2013 10-K 2015-09-14
Q3 2013 -$4.13M -$1.27M -$277K -27.9% Jul 1, 2013 Sep 30, 2013 10-K 2015-09-14
Q2 2013 -$3.86M -$994K +$211K +17.6% Apr 1, 2013 Jun 30, 2013 10-K 2015-09-14
Q1 2013 -$4.07M -$715K -$162K -29.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$3.91M -$1.15M -$526K -83.6% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 -$3.38M -$994K +$109K +9.85% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$3.49M -$1.21M -$493K -69.2% Apr 1, 2012 Jun 30, 2012 10-K 2013-09-30
Q1 2012 -$3M -$553K +$477K +46.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$3.47M -$629K -$401K -176% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-14
Q3 2011 -$3.07M -$1.1M -$230K -26.4% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$2.84M -$712K Apr 1, 2011 Jun 30, 2011 10-K/A 2012-10-26
Q1 2011 -$1.03M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 -$228K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 -$872K Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-12-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.